Results 121 to 130 of about 110,094 (223)

Primary Biliary Cholangitis Unmasked in Metabolic Dysfunction‐Associated Steatohepatitis: When a Correct Diagnosis Is Incomplete

The Kaohsiung Journal of Medical Sciences, EarlyView.
Yucheng Cheng, Yu‐Hsin Chuang, Ming‐Jong Bair, Jee‐Fu Huang   +3 more
wiley   +1 more source

Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Capsule sponge sampling with Endosign provides a safe, feasible and acceptable alternative to endoscopic biopsy for monitoring eosinophilic oesophagitis. In 164 paired assessments, eosinophil counts on capsule sponge cytology showed a strong correlation with endoscopic biopsy histology.
Rohith Kumar, Ayesha Rai, Kim Shaw, Erzsebet Santa, Francoise Cole, Hyesha McDonald, Pearl Baker, Lisa Mears, Anjan Dhar, Guiomar Moral‐Villarejo, Jacobo Ortiz Fernández‐Sordo, Ashraf Sanduka, Maria O'Donovan, Radina Georgieva, Sarah Killcoyne, Danielle L. Morris   +15 more
wiley   +1 more source

Long-Term Multisystem Comorbidity Patterns in Acute Pancreatitis: Insights From Observational and Genetic Analysis. [PDF]

United European Gastroenterol J
Che T, Fu T, Zhu Y, Ruan X, Sun Y, Geng J, Dan L, Wang X, Zhou C, Zou D, Arsenault BJ, Yuan S, Li X, Wang Z, Zhang X, Chen J, Zhang Y.   +16 more
europepmc   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

British Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman, Christopher J. Black, Andrea Shin, Daniel Keszthelyi   +3 more
wiley   +1 more source

A Genome-Wide Meta-Analysis of Functional Dyspepsia in 1,168,899 Individuals Implicates Immune Pathways in Disease Susceptibility. [PDF]

Neurogastroenterol Motil
Díaz-Muñoz C, Broeders B, Bonfiglio F, Zamfir-Taranu A, Arts J, Banovcin P, Bujanda L, Drug V, Dumitrascu D, Gourcerol G, Kindt S, Lipták P, Melchior C, Malagelada C, Savarino EV, Trikola A, Lehoucq J, Carbone F, Tack J, D'Amato M.   +19 more
europepmc   +1 more source

A New Clinical Paradigm: Stratified Gut Microbiota Interventions to Enhance Efficacy and Attenuate Toxicity of Cancer Immunotherapy

Microbiota Medicine Research, EarlyView.
Liang Zhang, Xinyu Du, Lijuan Sun, Ziyi Shi, Yongzhan Nie   +4 more
wiley   +1 more source

Rifaximin ameliorates memory impairment and Alzheimer's pathological changes in APP/PS1 mice associated with changes in the gut microbiome–bile acids–serum metabolites networks

British Journal of Pharmacology, EarlyView.
Background and Purpose Modifying the brain–gut–microbiota axis has emerged as a promising therapeutic strategy against Alzheimer's disease (AD). Whether rifaximin, a non‐absorbed and non‐systemic antibiotic, can be applied to the treatment of AD remains unexplored.
Di Wu, Mei‐Tong Nie, Jixian Lin, Yang Liu, Yong Wang, Min Chu, Lan Zheng, Jing Zhao   +7 more
wiley   +1 more source

Overweight BMI compromises survival and correlates with aggressive phenotypes in early-onset but not late-onset rectal cancer patients. [PDF]

Oncologist
Cai J, Li T, Weng J, Zhang Z, Han J, Li Z, Xu Z, Du Y, Lin J, Huang M, Wang X, Luo Y, Yu H.   +12 more
europepmc   +1 more source

Splenic Stiffness Measurement: A New Frontier in the Management of Pediatric Portal Hypertension

Portal Hypertension &Cirrhosis, EarlyView.
Samannay Das, Tamoghna Biswas
wiley   +1 more source

A Comparative Analysis Between Original and Updated Glucose Management Indicator and Glycated Haemoglobin Across Continuous Glucose Monitoring Sensors in Type 1 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The continuous glucose monitoring (CGM)‐derived glucose management indicator (GMI) is used for estimating glycated haemoglobin (HbA1c). This study assessed agreement between GMI—calculated using both original and updated (uGMI) models—and laboratory‐measured HbA1c across Dexcom, MiniMed and Abbott sensors. Materials and Methods Real‐world
Lavanta Farouk, Bilal Bashir, Rachel Seese, Parizad Avari, Monika Reddy, Richard M. Bergenstal, Viral N. Shah, Nick Oliver, Mark L. Evans, Hood Thabit, Lalantha Leelarathna   +10 more
wiley   +1 more source